(Q38081966)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Virus-like particle-based vaccines against hepatitis C virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

David Klatzmann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Bertrand Bellier

series ordinal

1

1 reference

28 August 2017

David Klatzmann

series ordinal

2

1 reference

28 August 2017

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

143-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

24 February 2020

cites work

1 reference

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

21 January 2018

1 reference

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

Hepatitis C virus entry: molecular biology and clinical implications

21 January 2018

1 reference

Antiviral strategies in hepatitis C virus infection

21 January 2018

1 reference

Resistance to direct antiviral agents in patients with hepatitis C virus infection

21 January 2018

1 reference

Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study

21 January 2018

1 reference

Development of hepatitis C virus vaccines: challenges and progress.

21 January 2018

1 reference

Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development

21 January 2018

1 reference

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

21 January 2018

1 reference

Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design

21 January 2018

1 reference

Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence

21 January 2018

1 reference

Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

21 January 2018

1 reference

Adaptive immune responses in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

21 January 2018

1 reference

Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion

21 January 2018

1 reference

The role of neutralizing antibodies in hepatitis C virus infection.

21 January 2018

1 reference

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees

21 January 2018

1 reference

Progress in the development of preventive and therapeutic vaccines for hepatitis C virus

21 January 2018

1 reference

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins

21 January 2018

1 reference

Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design

21 January 2018

1 reference

Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities

21 January 2018

1 reference

A new insight into hepatitis C vaccine development

21 January 2018

1 reference

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus

21 January 2018

1 reference

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

21 January 2018

1 reference

Vaccination for hepatitis C virus: closing in on an evasive target

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

21 January 2018

1 reference

CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus

21 January 2018

1 reference

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

21 January 2018

1 reference

Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus

21 January 2018

1 reference

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

Exploiting viral properties for the rational design of modern vaccines

21 January 2018

1 reference

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate

21 January 2018

1 reference

Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles

21 January 2018

1 reference

Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein

21 January 2018

1 reference

Hepatitis C Virus-Like Particle Budding: Role of the Core Protein and Importance of Its Asp111

21 January 2018

1 reference

Three-dimensional visualization of forming Hepatitis C virus-like particles by electron-tomography

21 January 2018

1 reference

Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture

21 January 2018

1 reference

Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding

21 January 2018

1 reference

A new model to produce infectious hepatitis C virus without the replication requirement

21 January 2018

1 reference

Baculovirus systems for the expression of human gene products

21 January 2018

1 reference

Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes

21 January 2018

1 reference

A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice

21 January 2018

1 reference

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

21 January 2018

1 reference

Uptake and presentation of hepatitis C virus-like particles by human dendritic cells

21 January 2018

1 reference

Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses

21 January 2018

1 reference

Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates

21 January 2018

1 reference

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

Virus-like particles: flexible platforms for vaccine development

21 January 2018

1 reference

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

21 January 2018

1 reference

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

21 January 2018

1 reference

Production in B. subtilis of hepatitis B core antigen and of major antigen of foot and mouth disease virus

21 January 2018

1 reference

Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes

21 January 2018

1 reference

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).

21 January 2018

1 reference

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.

21 January 2018

1 reference

Functions of the large hepatitis B virus surface protein in viral particle morphogenesis

21 January 2018

1 reference

Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes

21 January 2018

1 reference

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine

21 January 2018

1 reference

Development of cowpea mosaic virus-based vectors for the production of vaccines in plants

21 January 2018

1 reference

A Japanese Encephalitis Virus Peptide Present on Johnson Grass Mosaic Virus-Like Particles Induces Virus-Neutralizing Antibodies and Protects Mice against Lethal Challenge

21 January 2018

1 reference

Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites

21 January 2018

1 reference

Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

21 January 2018

1 reference

Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells

21 January 2018

1 reference

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

21 January 2018

1 reference

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins.

21 January 2018

1 reference

Studying HCV cell entry with HCV pseudoparticles (HCVpp).

21 January 2018

1 reference

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

21 January 2018

1 reference

Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads

21 January 2018

1 reference

A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques

21 January 2018

1 reference

Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins

21 January 2018

1 reference

Characterization of pseudotype VSV possessing HCV envelope proteins

21 January 2018

1 reference

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles

21 January 2018

1 reference

Human infection with the virus of vesicular stomatitis during an epizootic

21 January 2018

1 reference

Vesicular stomatitis virus as an oncolytic vector

21 January 2018

1 reference

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases

21 January 2018

1 reference

Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector

21 January 2018

1 reference

Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle

21 January 2018

1 reference

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins

21 January 2018

1 reference

Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly

21 January 2018

1 reference

Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles

21 January 2018

1 reference

Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis

21 January 2018

1 reference

Structural requirements for assembly and homotypic interactions of the hepatitis C virus core protein

21 January 2018

1 reference

Immunization with a DNA vaccine encoding the hepatitis-C-virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (crab-eating macaque monkeys).

21 January 2018

1 reference

Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.

21 January 2018

1 reference

DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.

21 January 2018

1 reference

DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies

21 January 2018

1 reference

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

21 January 2018

1 reference

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.

21 January 2018

1 reference

New adjuvants in evolving vaccine strategies.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.13.10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23414406%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference